Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Secondary Hyperparathyroidism Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Surgery 1.4.3 Drugs 1.4.4 Vitamin D 1.4.5 Calcimimetics 1.4.6 Phosphate Binders 1.5 Market by Application 1.5.1 Global Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2025) 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Secondary Hyperparathyroidism Treatment Market Size 2.2 Secondary Hyperparathyroidism Treatment Growth Trends by Regions 2.2.1 Secondary Hyperparathyroidism Treatment Market Size by Regions (2014-2025) 2.2.2 Secondary Hyperparathyroidism Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Secondary Hyperparathyroidism Treatment Market Size by Manufacturers 3.1.1 Global Secondary Hyperparathyroidism Treatment Revenue by Manufacturers (2014-2019) 3.1.2 Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Secondary Hyperparathyroidism Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Secondary Hyperparathyroidism Treatment Key Players Head office and Area Served 3.3 Key Players Secondary Hyperparathyroidism Treatment Product/Solution/Service 3.4 Date of Enter into Secondary Hyperparathyroidism Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) 4.2 Global Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) 5 United States 5.1 United States Secondary Hyperparathyroidism Treatment Market Size (2014-2019) 5.2 Secondary Hyperparathyroidism Treatment Key Players in United States 5.3 United States Secondary Hyperparathyroidism Treatment Market Size by Type 5.4 United States Secondary Hyperparathyroidism Treatment Market Size by Application 6 Europe 6.1 Europe Secondary Hyperparathyroidism Treatment Market Size (2014-2019) 6.2 Secondary Hyperparathyroidism Treatment Key Players in Europe 6.3 Europe Secondary Hyperparathyroidism Treatment Market Size by Type 6.4 Europe Secondary Hyperparathyroidism Treatment Market Size by Application 7 China 7.1 China Secondary Hyperparathyroidism Treatment Market Size (2014-2019) 7.2 Secondary Hyperparathyroidism Treatment Key Players in China 7.3 China Secondary Hyperparathyroidism Treatment Market Size by Type 7.4 China Secondary Hyperparathyroidism Treatment Market Size by Application 8 Japan 8.1 Japan Secondary Hyperparathyroidism Treatment Market Size (2014-2019) 8.2 Secondary Hyperparathyroidism Treatment Key Players in Japan 8.3 Japan Secondary Hyperparathyroidism Treatment Market Size by Type 8.4 Japan Secondary Hyperparathyroidism Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Secondary Hyperparathyroidism Treatment Market Size (2014-2019) 9.2 Secondary Hyperparathyroidism Treatment Key Players in Southeast Asia 9.3 Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Type 9.4 Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Application 10 India 10.1 India Secondary Hyperparathyroidism Treatment Market Size (2014-2019) 10.2 Secondary Hyperparathyroidism Treatment Key Players in India 10.3 India Secondary Hyperparathyroidism Treatment Market Size by Type 10.4 India Secondary Hyperparathyroidism Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Secondary Hyperparathyroidism Treatment Market Size (2014-2019) 11.2 Secondary Hyperparathyroidism Treatment Key Players in Central & South America 11.3 Central & South America Secondary Hyperparathyroidism Treatment Market Size by Type 11.4 Central & South America Secondary Hyperparathyroidism Treatment Market Size by Application 12 International Players Profiles 12.1 Amgen 12.1.1 Amgen Company Details 12.1.2 Company Description and Business Overview 12.1.3 Secondary Hyperparathyroidism Treatment Introduction 12.1.4 Amgen Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) 12.1.5 Amgen Recent Development 12.2 OPKO Health 12.2.1 OPKO Health Company Details 12.2.2 Company Description and Business Overview 12.2.3 Secondary Hyperparathyroidism Treatment Introduction 12.2.4 OPKO Health Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) 12.2.5 OPKO Health Recent Development 12.3 AbbVie 12.3.1 AbbVie Company Details 12.3.2 Company Description and Business Overview 12.3.3 Secondary Hyperparathyroidism Treatment Introduction 12.3.4 AbbVie Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) 12.3.5 AbbVie Recent Development 12.4 Astellas Pharma 12.4.1 Astellas Pharma Company Details 12.4.2 Company Description and Business Overview 12.4.3 Secondary Hyperparathyroidism Treatment Introduction 12.4.4 Astellas Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) 12.4.5 Astellas Pharma Recent Development 12.5 Roche 12.5.1 Roche Company Details 12.5.2 Company Description and Business Overview 12.5.3 Secondary Hyperparathyroidism Treatment Introduction 12.5.4 Roche Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) 12.5.5 Roche Recent Development 12.6 KAI Pharmaceuticals 12.6.1 KAI Pharmaceuticals Company Details 12.6.2 Company Description and Business Overview 12.6.3 Secondary Hyperparathyroidism Treatment Introduction 12.6.4 KAI Pharmaceuticals Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) 12.6.5 KAI Pharmaceuticals Recent Development 12.7 Kyowa Hakko Kirin 12.7.1 Kyowa Hakko Kirin Company Details 12.7.2 Company Description and Business Overview 12.7.3 Secondary Hyperparathyroidism Treatment Introduction 12.7.4 Kyowa Hakko Kirin Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) 12.7.5 Kyowa Hakko Kirin Recent Development 12.8 Leo Pharma 12.8.1 Leo Pharma Company Details 12.8.2 Company Description and Business Overview 12.8.3 Secondary Hyperparathyroidism Treatment Introduction 12.8.4 Leo Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) 12.8.5 Leo Pharma Recent Development 12.9 Shire 12.9.1 Shire Company Details 12.9.2 Company Description and Business Overview 12.9.3 Secondary Hyperparathyroidism Treatment Introduction 12.9.4 Shire Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) 12.9.5 Shire Recent Development 12.10 Sanofi 12.10.1 Sanofi Company Details 12.10.2 Company Description and Business Overview 12.10.3 Secondary Hyperparathyroidism Treatment Introduction 12.10.4 Sanofi Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) 12.10.5 Sanofi Recent Development 12.11 Deltanoid Pharmaceuticals 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Secondary Hyperparathyroidism Treatment Key Market Segments Table Key Players Secondary Hyperparathyroidism Treatment Covered Table Global Secondary Hyperparathyroidism Treatment Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Secondary Hyperparathyroidism Treatment Market Size Market Share by Type 2014-2025 Figure Surgery Figures Table Key Players of Surgery Figure Drugs Figures Table Key Players of Drugs Figure Vitamin D Figures Table Key Players of Vitamin D Figure Calcimimetics Figures Table Key Players of Calcimimetics Figure Phosphate Binders Figures Table Key Players of Phosphate Binders Table Global Secondary Hyperparathyroidism Treatment Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Pharmacies Case Studies Figure Retail Pharmacies Case Studies Figure Secondary Hyperparathyroidism Treatment Report Years Considered Table Global Secondary Hyperparathyroidism Treatment Market Size 2014-2025 (Million US$) Figure Global Secondary Hyperparathyroidism Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Secondary Hyperparathyroidism Treatment Market Size by Regions 2014-2025 (Million US$) Table Global Secondary Hyperparathyroidism Treatment Market Size by Regions 2014-2019 (Million US$) Table Global Secondary Hyperparathyroidism Treatment Market Share by Regions 2014-2019 Figure Global Secondary Hyperparathyroidism Treatment Market Share by Regions 2014-2019 Figure Global Secondary Hyperparathyroidism Treatment Market Share by Regions 2019 Table Market Top Trends Table Global Secondary Hyperparathyroidism Treatment Revenue by Manufacturers (2014-2019) (Million US$) Table Global Secondary Hyperparathyroidism Treatment Market Share by Manufacturers (2014-2019) Figure Global Secondary Hyperparathyroidism Treatment Market Share by Manufacturers in 2018 Table Global Secondary Hyperparathyroidism Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Secondary Hyperparathyroidism Treatment Product/Solution/Service Table Date of Enter into Secondary Hyperparathyroidism Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$) Table Global Secondary Hyperparathyroidism Treatment Market Size Share by Type (2014-2019) Figure Global Secondary Hyperparathyroidism Treatment Market Size Market Share by Type (2014-2019) Table Global Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$) Table Global Secondary Hyperparathyroidism Treatment Market Size Share by Application (2014-2019) Figure Global Secondary Hyperparathyroidism Treatment Market Size Market Share by Application (2014-2019) Figure Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Application in 2018 Figure United States Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$) Table United States Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$) Table United States Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019) Table United States Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$) Table United States Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019) Table United States Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$) Table United States Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019) Figure Europe Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019) Table Europe Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$) Table Europe Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019) Table Europe Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$) Table Europe Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019) Figure China Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$) Table China Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$) Table China Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019) Table China Secondary Hyperparathyroidism Treatment Market Size by Type (2014-20189) (Million US$) Table China Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019) Table China Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$) Table China Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019) Figure Japan Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019) Table Japan Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$) Table Japan Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019) Table Japan Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$) Table Japan Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019) Figure Southeast Asia Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019) Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019) Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019) Figure India Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$) Table India Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$) Table India Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019) Table India Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$) Table India Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019) Table India Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$) Table India Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019) Figure Central & South America Secondary Hyperparathyroidism Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Secondary Hyperparathyroidism Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Secondary Hyperparathyroidism Treatment Market Share (2018-2019) Table Central & South America Secondary Hyperparathyroidism Treatment Market Size by Type (2014-2019) (Million US$) Table Central & South America Secondary Hyperparathyroidism Treatment Market Share by Type (2014-2019) Table Central & South America Secondary Hyperparathyroidism Treatment Market Size by Application (2014-2019) (Million US$) Table Central & South America Secondary Hyperparathyroidism Treatment Market Share by Application (2014-2019) Table Amgen Company Details Table Amgen Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019) (Million US$) Figure Amgen Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019) Table Amgen Recent Development Table OPKO Health Company Details Table OPKO Health Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$) Figure OPKO Health Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019) Table OPKO Health Recent Development Table AbbVie Company Details Table AbbVie Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$) Figure AbbVie Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019) Table AbbVie Recent Development Table Astellas Pharma Company Details Table Astellas Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$) Figure Astellas Pharma Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019) Table Astellas Pharma Recent Development Table Roche Company Details Table Roche Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019) Table Roche Recent Development Table KAI Pharmaceuticals Company Details Table KAI Pharmaceuticals Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$) Figure KAI Pharmaceuticals Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019) Table KAI Pharmaceuticals Recent Development Table Kyowa Hakko Kirin Company Details Table Kyowa Hakko Kirin Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$) Figure Kyowa Hakko Kirin Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019) Table Kyowa Hakko Kirin Recent Development Table Leo Pharma Company Details Table Leo Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$) Figure Leo Pharma Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019) Table Leo Pharma Recent Development Table Shire Company Details Table Shire Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$) Figure Shire Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019) Table Shire Recent Development Table Sanofi Company Details Table Sanofi Revenue in Secondary Hyperparathyroidism Treatment Business (2014-2019)(Million US$) Figure Sanofi Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2014-2019) Table Sanofi Recent Development Table Deltanoid Pharmaceuticals Company Details Table Global Secondary Hyperparathyroidism Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Secondary Hyperparathyroidism Treatment Market Size Share by Regions (2019-2025) Figure Global Secondary Hyperparathyroidism Treatment Market Size Share by Regions in 2025 Figure United States Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Secondary Hyperparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Secondary Hyperparathyroidism Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Secondary Hyperparathyroidism Treatment Market Size by Product (2019-2025) Figure Global Secondary Hyperparathyroidism Treatment Market Size by Product in 2025 Table Global Secondary Hyperparathyroidism Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Secondary Hyperparathyroidism Treatment Market Size by Application (2019-2025) Figure Global Secondary Hyperparathyroidism Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Amgen OPKO Health AbbVie Astellas Pharma Roche KAI Pharmaceuticals Kyowa Hakko Kirin Leo Pharma Shire Sanofi Deltanoid Pharmaceuticals